These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1377741)

  • 21. Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial.
    Lancet; 1997 May; 349(9063):1413-21. PubMed ID: 9164314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isoprinosine and Imuthiol, two potentially active compounds in patients with AIDS-related complex symptoms.
    Pompidou A; Delsaux MC; Telvi L; Mace B; Coutance F; Falkenrodt A; Lang JM
    Cancer Res; 1985 Sep; 45(9 Suppl):4671s-4673s. PubMed ID: 2410111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acyclovir vs isoprinosine (immunovir) for suppression of recurrent genital herpes simplex infection.
    Kinghorn GR; Woolley PD; Thin RN; De Maubeuge J; Foidart JM; Engst R
    Genitourin Med; 1992 Oct; 68(5):312-6. PubMed ID: 1385295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isoprinosine treatment of alopecia areata.
    Thiers BH
    J Invest Dermatol; 1991 May; 96(5):72S-73S. PubMed ID: 1708797
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of disease progression and zidovudine therapy on semen quality in human immunodeficiency virus type 1 seropositive men.
    Politch JA; Mayer KH; Abbott AF; Anderson DJ
    Fertil Steril; 1994 May; 61(5):922-8. PubMed ID: 8174732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral phenotype and T cell reactivity in human immunodeficiency virus type 1-infected asymptomatic men treated with zidovudine.
    Koot M; Schellekens PT; Mulder JW; Lange JM; Roos MT; Coutinho RA; Tersmette M; Miedema F
    J Infect Dis; 1993 Sep; 168(3):733-6. PubMed ID: 8102631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Isoprinosine treatment of herpes zoster. Résults of a control study in 36 subjects (author's transl)].
    Lesourd B; Laude J; Meunier P; Doumerc S; Moulias R
    Nouv Presse Med; 1982 Jan; 11(3):191-3. PubMed ID: 6173843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group.
    BMJ; 1992 Jan; 304(6818):13-7. PubMed ID: 1346505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.
    Volberding PA; Lagakos SW; Grimes JM; Stein DS; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS; Phair JP; Mitsuyasu RT
    JAMA; 1994 Aug; 272(6):437-42. PubMed ID: 7913730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of zidovudine and concomitant inosine-pranobex in AIDS patients.
    De Simone C; Ferrazzi M; Bitonti F; Falciano M; Tzantzoglou S; Delia S; Sorice F
    Immunopharmacol Immunotoxicol; 1988; 10(4):437-41. PubMed ID: 2469710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial.
    Lane HC; Falloon J; Walker RE; Deyton L; Kovacs JA; Masur H; Banks S; Kirk LE; Baseler MW; Salzman NP
    Ann Intern Med; 1989 Jul; 111(1):41-50. PubMed ID: 2735626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-vivo immunomodulation by isoprinosine in patients with the acquired immunodeficiency syndrome and related complexes.
    Grieco MH; Reddy MM; Manvar D; Ahuja KK; Moriarty ML
    Ann Intern Med; 1984 Aug; 101(2):206-7. PubMed ID: 6204566
    [No Abstract]   [Full Text] [Related]  

  • 33. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
    Moyle GJ; Bouza E; Antunes F; Smith D; Harris R; Warburg M; Walker M
    Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trials of zidovudine in HIV infection.
    Lancet; 1989 Aug; 2(8661):483-4. PubMed ID: 2570190
    [No Abstract]   [Full Text] [Related]  

  • 35. A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team.
    Sáez-Llorens X; Nelson RP; Emmanuel P; Wiznia A; Mitchell C; Church JA; Sleasman J; Van Dyke R; Richardson CG; Cutrell A; Spreen W; Hetherington S
    Pediatrics; 2001 Jan; 107(1):E4. PubMed ID: 11134468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex.
    Pedersen C; Cooper DA; Brun-Vézinet F; Doherty R; Skinhøj P; Pérol Y; Lüthy R; Leibowitch J; Habermehl KO; Varnier OE
    AIDS; 1992 Aug; 6(8):821-5. PubMed ID: 1418778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Isoprinosine therapy in chronic hepatitis C (multicenter placebo-controlled double-blind prospective study)].
    Pár A; Beró T; Brasch G; Gógl A; Kamarás G; Méhesfalvi E; Ozsvár Z; Paál M; Szipöcs I; Telegdy L
    Orv Hetil; 1993 May; 134(19):1015-9. PubMed ID: 7684118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group.
    Cooper DA; Pehrson PO; Pedersen C; Moroni M; Oksenhendler E; Rozenbaum W; Clumeck N; Faber V; Stille W; Hirschel B
    AIDS; 1993 Feb; 7(2):197-207. PubMed ID: 8096703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxic effects of zidovudine in asymptomatic human immunodeficiency virus-infected individuals with CD4+ cell counts of 0.50 x 10(9)/L or less. Detailed and updated results from protocol 019 of the AIDS Clinical Trials Group.
    Koch MA; Volberding PA; Lagakos SW; Booth DK; Pettinelli C; Myers MW
    Arch Intern Med; 1992 Nov; 152(11):2286-92. PubMed ID: 1359846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunotherapy in a case of AIDS with Kaposi's sarcoma--an unsuccessful attempt with recombinant alpha-2 interferon followed by isoprinosine.
    Roupe G; Håkansson C; Löwhagen GB
    Int Arch Allergy Appl Immunol; 1987; 82(1):17-9. PubMed ID: 2433223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.